These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8362520)

  • 1. Dose of anti-D immunoglobulin for the prevention of RhD immunisation after RhD-incompatible platelet transfusions.
    Murphy MF; Lee D
    Vox Sang; 1993; 65(1):73-4. PubMed ID: 8362520
    [No Abstract]   [Full Text] [Related]  

  • 2. A dose of 100 IU intravenous anti-D gammaglobulin is effective for the prevention of RhD immunisation after RhD-incompatible single donor platelet transfusion.
    Zeiler T; Wittmann G; Zingsem J; Weisbach V; Zimmermann R; Eckstein R
    Vox Sang; 1994; 66(3):243. PubMed ID: 8036796
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous anti-D gammaglobulin for the prevention of rhesus isoimmunization caused by platelet transfusions in patients with malignant diseases.
    Heim MU; Böck M; Kolb HJ; Schleuning M; Mempel W
    Vox Sang; 1992; 62(3):165-8. PubMed ID: 1319096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is it necessary to administer anti-D to prevent RhD immunization after the transfusion of RhD-positive platelet concentrates?
    Atoyebi W; Mundy N; Croxton T; Littlewood TJ; Murphy MF
    Br J Haematol; 2000 Dec; 111(3):980-3. PubMed ID: 11122163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rh immune globulin immunoprophylaxis after RhD-positive red cell exposure in RhD-negative patients via transfusion: A survey of practices.
    Lu W; Stephens L; Shmookler A; O'Brien K; Karp JK; Hermelin D; Bakhtary S; Almozain N; George M; Fung M
    Transfusion; 2024 May; 64(5):839-845. PubMed ID: 38534065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transfusions of rhesus-incompatible platelet concentrates in Rouen University Hospital: procedures and consequences].
    Chamouni P; Josset V; Bastit D; Tavolacci MP; Lenain P; Varin R; Czernichow P
    Transfus Clin Biol; 2005 Oct; 12(4):306-12. PubMed ID: 16169273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion of RhD-incompatible blood components in RhD-negative blood marrow transplant recipients.
    Asfour M; Narvios A; Lichtiger B
    MedGenMed; 2004 Jul; 6(3):22. PubMed ID: 15520646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of maternal RhD isoimmunization with anti-D gamma isoimmunization].
    Baptista-González HA; Rosenfeld-Mann F; Leiss-Márquez T
    Salud Publica Mex; 2001; 43(1):52-8. PubMed ID: 11270285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of fetal erythroblastosis with anti-D immunoglobulin].
    Rasteński J; Gryglicka M
    Acta Haematol Pol; 1988; 19(3-4):239-41. PubMed ID: 3150900
    [No Abstract]   [Full Text] [Related]  

  • 10. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
    Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
    Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute renal failure with hemolysis in a D-mismatched transfusion recipient treated with RhIG.
    Karp JK; Ness PM
    Transfusion; 2009 Jun; 49(6):1269; author reply 1269-70. PubMed ID: 19638156
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical contribution to the study of the frequency and gravity of anti-Rh isoimmunization induced by Rh incompatible transfusions].
    CALLEGARI G
    Riv Ostet Ginecol Prat; 1961 Nov; 43():912-9. PubMed ID: 13875781
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 14. Failure to prevent rhesus immunisation with rhesus immune globulin after incompatible blood transfusion.
    Branch DW; Guyman G; Scott JR
    Lancet; 1985 Feb; 1(8425):393-4. PubMed ID: 2857440
    [No Abstract]   [Full Text] [Related]  

  • 15. [Platelet transfusion and immunization anti-Rh1: implication for immunoprophylaxis].
    Chambost H
    Transfus Clin Biol; 2014 Nov; 21(4-5):210-5. PubMed ID: 25282489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoprophylactic anti-Rho(D) treatment after mismatched transfusions.
    Ennker J; Maas DH; Schneider J
    Eur J Obstet Gynecol Reprod Biol; 1979 Apr; 9(2):117-24. PubMed ID: 233744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is current serologic RhD typing of blood donors sufficient for avoiding immunization of recipients?
    Krog GR; Clausen FB; Berkowicz A; Jørgensen L; Rieneck K; Nielsen LK; Dziegiel MH
    Transfusion; 2011 Nov; 51(11):2278-85. PubMed ID: 21569040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal Rh immunoglobulin--help or hindrance?
    Pisciotto P; Gorbants I; Sundra M
    Transfusion; 1985; 25(1):88. PubMed ID: 2982225
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoprophylaxis with anti D immunoglobulins in Rh negative women.
    Gupta I; Jolly JG; Gupta AN
    Indian J Med Res; 1987 Jun; 85():656-8. PubMed ID: 2824352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.